Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate to prevent GFR decline in stage 3–5 chronic kidney disease
IRCT20250118064415N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of potassium citrate in chronic kidney disease (CKD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in GFR. Started Feb 2025; status: completed.
02
Drugs
potassium citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20250118064415N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250118064415N1.